TrialMultiple sclerosis and related disorders2017

Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years.

Fred D Lublin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.